article thumbnail

[PARAMETERS UPDATE P5.8] EBITDA MULTIPLES

Equidam

You can refer to the table below to see how the EBITDA multiples for the industries available on the Equidam platform will change on February 29th, 2024. The data is based on the early 2024 estimate, published annually by Prof. Industry EBITDA Multiple Old New Var % Advanced Medical Equipment & Technology 20.99

EBITDA 59
article thumbnail

Standard BioTools Reports Third Quarter 2024 Financial Results

Benzinga

30, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. NASDAQ: LAB ) (the "Company") today announced unaudited interim financial results for the third quarter ended September 30, 2024. million in the third quarter of 2024, down 5% year-over-year: Consumables revenue was $14.0 SOUTH SAN FRANCISCO, Calif.,

EBITDA 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

2024 Global Technology, Media & Telecom Industry Report

Benchmark Report

In 2024, spending on the information technology (IT) sector is forecast to rebound to 8%, up from 4% in 2023. The year 2024 will be when the media sector begins to see improved EBITDA and cash flow. Streaming losses are also expected to lessen, improving on a trend that started in 2023.

article thumbnail

LLYC's operating revenue grows 12% in the first half of 2024, reaching 43.2 million euros

Benzinga

drives business growth Effective expense management has led to an EBITDA margin of 16% The firm concludes a record-breaking semester in investments. 2024 is shaping up to be a transformational year for the company MIAMI, Oct. 15, 2024 (GLOBE NEWSWIRE) -- LLYC (BME:LLYC) closed the first half of 2024 with an operating revenue of 43.2

EBITDA 40
article thumbnail

Retail Opportunity Investments Corp. Reports 2024 Third Quarter Results

Benzinga

22, 2024 (GLOBE NEWSWIRE) -- Retail Opportunity Investments Corp. NASDAQ: ROIC ) announced today financial and operating results for the three and nine months ended September 30, 2024. per diluted share) FFO per diluted share guidance for 2024 updated ($1.03 - $1.05 net principal debt-to-annualized EBITDA ratio for 3Q‘24 (vs.

article thumbnail

Tornetta v. Musk: Post-Trial Opinion

Harvard Corporate Governance

Posted by Anna Restuccia (Harvard Law School), on Thursday, February 1, 2024 Editor's Note: This post provides the text of the post-trial opinion regarding the case between Richard J. against Elon Musk, decided by the Delaware Court of Chancery on January 30, 2024. Tornetta on behalf of Tesla, Inc. Varallo, Glenn R. With a $55.8

EBITDA 337
article thumbnail

Revenue Multiples by Industry in 2024

Equidam

Aswath Damodaran of the New York University for 2024. Revenue multiples are a particularly crude tool in valuation, which is why the Equidam platform uses EBITDA multiples by default. Industry EBITDA Multiple Advanced Medical Equipment & Technology 5.25 Industry EBITDA Multiple Advanced Medical Equipment & Technology 5.25

EBITDA 59